S. Butler

Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.

J. Elborn, D. Shale, A. Webb, 2000, The Journal of infection.

Is there a difference in airway clearance practices between children with non cystic fibrosis bronchiectasis and cystic fibrosis

C. Byrnes, J. Harrison, C. Takai, 2008 .

Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard?

J. Govan, C. Doherty, J. E. Hughes, 1995, Journal of clinical microbiology.

Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.

J. Govan, I. Simpson, D. Winstanley, 1994, The Journal of antimicrobial chemotherapy.

Virulence factors of Burkholderia cepacia.

J. Govan, J. Nelson, S. Butler, 1994, FEMS immunology and medical microbiology.

Serum sensitivity of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis.

J. Govan, I. Poxton, J. Nelson, 1994, FEMS immunology and medical microbiology.

Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.

J. Govan, A. Greening, P. Brown, 1993, Journal of medical microbiology.